VSTM Share Price

Open 1.21 Change Price %
High 1.23 1 Day -0.01 -0.83
Low 1.16 1 Week -0.03 -2.44
Close 1.20 1 Month -0.10 -7.69
Volume 111957 1 Year 0.06 5.26
52 Week High 1.93
52 Week Low 1.05
VSTM Important Levels
Resistance 2 1.26
Resistance 1 1.24
Pivot 1.20
Support 1 1.16
Support 2 1.14
NASDAQ USA Most Active Stocks
NVDA 100.49 -9.27%
JBHT 97.31 -1.05%
AREX 2.96 -1.99%
OZRK 55.54 1.02%
FNSR 34.15 0.12%
AGNC 19.64 0.72%
EA 86.65 -0.84%
FNFG 10.18 -0.20%
PRFZ 118.04 -0.80%
DELL 13.86 0.22%
More..
NASDAQ USA Top Gainers Stocks
ECTE 0.18 50.00%
LOCM 0.09 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
ZAZA 0.06 20.00%
JAKK 5.70 12.87%
LINE 0.18 12.50%
More..
NASDAQ USA Top Losers Stocks
DEER 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
More..

Verastem, Inc. (NASDAQ: VSTM)

VSTM Technical Analysis 2
As on 23rd Feb 2017 VSTM Share Price closed @ 1.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.33 & Buy for SHORT-TERM with Stoploss of 1.19 we also expect STOCK to react on Following IMPORTANT LEVELS.
VSTM Target for February
1st Target up-side 1.41
2nd Target up-side 1.5
3rd Target up-side 1.6
1st Target down-side 1.13
2nd Target down-side 1.04
3rd Target down-side 0.94
VSTM Other Details
Segment EQ
Market Capital 171709120.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.verastem.com
VSTM Address
VSTM
215 First Street
Suite 440
Cambridge, MA 02142
United States
Phone: 617-252-9300
VSTM Latest News
Notable movements of Stock: Verastem, Inc.'s (VSTM) share price has value at ...   Street Updates   - 23rd Feb 17
Noteworthy Buzzer: Verastem, Inc. (NASDAQ:VSTM)   Is stories   - 21st Feb 17
EPS Of Verastem, Inc. (NASDAQ:VSTM) At $-0.27   Stock Observer   - 19th Feb 17
Verastem to Present at 19th Annual BIO CEO & Investor Conference   Yahoo Finance   - 07th Feb 17
A New Kind of Stock Chart: Verastem Inc (NASDAQ:VSTM) Critical Pivot Points   CML News   - 10th Jan 17
Beaten-down biotechs pin hopes on drug-licensing deal   The Boston Globe   - 03rd Nov 16
Verastem Announces the Presentation of Clinical Data at iMig 2016   Business Wire (press release)   - 03rd May 16
Verastem Names Gregory I. Berk, MD as Chief Medical Officer   Business Wire (press release)   - 19th Apr 16
Verastem shares plunge as drug trial fails   The Boston Globe   - 29th Sep 15
Verastem Inc.   MarketWatch   - 27th Jan 12
Interactive Technical Analysis Chart Verastem, Inc. ( VSTM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Verastem, Inc.
VSTM Business Profile
Verastem, Inc. is a clinical biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. The Company also develops companion diagnostics. The Company has technology to create a stable population of cancer stem cells that it uses to screen for and identify small molecule compounds that target cancer stem cells. The Company�s advanced programs target the Focal Adhesion Kinase (FAK), and the PI3K/mTOR signaling pathways. The Company�s lead FAK inhibitor, VS-6063, is in Phase 1/1b testing in ovarian cancer. The Company�s solution is to discover and develop an oncology therapeutics targeting CSCs along with companion diagnostics. The Company is focused on the discovery and development of small molecules to allow flexibility in the design of molecules for optimized efficacy and safety primarily as orally available drug candidates.